VistaGen Therapeutics Inc (VTGN): Press Release: Vistagen To Report First...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	1006
Posts	43300
Boards Moderated	0
Alias Born	03/17/2014

Hercules1

Re: None

Tuesday, 08/08/2023 6:18:58 PM

Tuesday, August 08, 2023 6:18:58 PM

Press Release: Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023
5:19 pm ET August 8, 2023 (Dow Jones) Print
Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--August 08, 2023--
Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (CNS) disorders, today announced it will host a conference call and webcast on Thursday, August 10, 2023, at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and report results for its fiscal year 2024 first quarter ended June 30, 2023.

Event: Vistagen Fiscal Year 2024 First Quarter Corporate Update Conference Call

Date: Thursday, August 10, 2023

Time: 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time)

US Dial-in (Toll-free): 1-800-954-1051

TOLL/International Dial-in: 1-212-231-2924

Conference ID: 22027732

Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1627439&tp_key=9f0f4cb009